Skip to main content
Clinical Trials/ISRCTN31345163
ISRCTN31345163
Completed
N/A

GENetic and clinical Predictors Of treatment response in Depressio

Medical Research Council (UK)0 sites887 target enrollmentSeptember 19, 2003

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Medical Research Council (UK)
Enrollment
887
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 19, 2003
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Medical Research Council (UK)

Eligibility Criteria

Inclusion Criteria

  • 18\-74 years with the more severe depressions in whom the GP and patient have already agreed that antidepressants should be prescribed. We will therefore only include those with a Clinical Interview Schedule \- Revised (CIS\-R) score of \=20, a Beck Depression Inventory (BDI) score of \=15 and a diagnosis of International Statistical Classification of Diseases and Related Health Problems, tenth revision (ICD\-10\) depressive episode F32 and F33 (from CIS\-R).

Exclusion Criteria

  • Pregnant and breast feeding women, patients with psychotic illness, alchohol or substance abuse problems, patients with medical contraindications to Citalopram or Reboxetine. (June 2006: Exclusion criteria were provided as follows: Potential subjects who have taken antidepressant medication within 2 weeks, who cannot complete self\-administered scales, who have a psychosis or major substance or alcohol abuse. The GP will exclude anyone who has medical contraindications or in whom participation in the trial is not appropriate.)

Outcomes

Primary Outcomes

Not specified

Similar Trials